Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Norepinephrine storage vesicles are specialized organelles within noradrenergic neurons and certain other cell types that store the neurotransmitter norepinephrine (also known as noradrenaline) prior to its release into the synaptic cleft or extracellular space. These vesicles play a critical role in regulating neurotransmission, ensuring rapid and controlled release of norepinephrine in response to neuronal signals. They function by storing norepinephrine after uptake via VMAT, releasing it via exocytosis, and participating in recycling after reuptake. There are small dense-cored and large dense-cored vesicles. Agents like reserpine inhibit VMAT function, depleting norepinephrine and reducing neurotransmitter availability.
VMAT inhibitors prevent norepinephrine uptake into storage vesicles, leading to depletion of norepinephrine stores and reduced neurotransmission.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Norepinephrine Storage Vesicles.